Vanguard Group Inc Champions Oncology, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 307,874 shares of CSBR stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
307,874
Previous 307,002
0.28%
Holding current value
$1.81 Million
Previous $2.63 Million
1.56%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CSBR
# of Institutions
39Shares Held
5.95MCall Options Held
43.4KPut Options Held
2.1K-
Battery Management Corp. Boston, MA2.42MShares$14.2 Million3.06% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$10.1 Million1.41% of portfolio
-
Tocqueville Asset Management L.P. New York, NY400KShares$2.35 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny152KShares$892,4680.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA127KShares$742,7310.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $79.4M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...